Queen Elizabeth ll Health Sciences Centre
Halifax, Nova Scotia, B3H 3A7, Canada
NCT Number: NCT01290991
Is Augment Bone Graft plus Allograft safe to use for the treatment of osteochondral defects of the knee?
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Halifax, Nova Scotia, B3H 3A7, Canada
Subjects will be 18 to 40 years with an osteochondral defects of the knee.They will be candidates for allograft and Augment Bone Graft will be added to the procedure. The safety of Augment Bone Graft plus allograft for osteochondral defects of the knee will be evaluated by type, frequency, severity and relatedness of adverse events to the device for a minimum of 24 weeks.Magnetic Resonance Imaging will be performed at 1,12 and 42 weeks to evaluate device integrity and surgical treatment of osteochondral defects. Computed tomography will be done at week 1 and week 24 to determine the healing status of the osteochondral defect.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion:
Augment Bone Graft physically fills bone defects by providing a biocompatible scaffold for new bone formation.The material is comprised of a matrix of beta tricalcium phosphate and a highly purified recombinant human platelet-derived growth factor.
Other names: Bone Graft
Time frame: 12 months
Collection of related adverse events
Time frame: 12 months
Assess healing and bone formation from radiological reports
Nova Scotia Health Authority
Other
A Pilot Study to Augment™ Bone Graft Plus Evaluate the Safety of Allograft for Treatment of Osteochondral Defects (OCD) of the Knee
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02519881
Defect of Articular Cartilage, Fractures, Bone
Bucheon-si, Gyeonggi-do, South Korea
View Trial DetailsNCT02524509
Articular Cartilage Disorder of Knee, Defect of Articular Cartilage
Incheon, Inchoen, South Korea
View Trial DetailsNCT02696876
Arthritis, Cartilage Injury
Leeds, West Yorkshire, United Kingdom
View Trial DetailsNCT01473199
Cartilage Damage, Cartilage Injury
Chester, England, United Kingdom
View Trial Details